MyFinsight
Home
Blog
About
Back
Income Statement
Monopar Therapeutics (MNPR)
Monopar Therapeutics (MNPR)
source: myfinsight.com
Comprehensive income (loss)
-$5,320.505K
(-126.00%↓ Y/Y)
Foreign currency
translation gain (loss), net
$0.516K
(114.93%↑ Y/Y)
Net income (loss)
-$5,313.3K
(-116.56%↓ Y/Y)
Unrealized gain (loss) on
investments, net
-$7.721K
(-107.51%↓ Y/Y)
Interest income (loss)
$1,299.205K
(66.40%↑ Y/Y)
Other income (loss)
$32.158K
Income (loss) from
operations
-$6,644.663K
(-105.44%↓ Y/Y)
Total operating
expenses
$6,644.663K
(105.44%↑ Y/Y)
Research and development
$4,766.832K
(175.54%↑ Y/Y)
General and
administrative
$1,877.831K
(24.83%↑ Y/Y)
Back